| A cancer stem cell-like phenotype is associated with miR-10b expression in aggressive squamous cell carcinomas M Wimmer, R Zauner, M Ablinger, J Piñón-Hofbauer, C Guttmann-Gruber, ... Cell Communication and Signaling 18, 1-15, 2020 | 26 | 2020 |
| Personalized development of antisense oligonucleotides for exon skipping restores type XVII collagen expression in junctional epidermolysis bullosa M Ablinger, T Lettner, N Friedl, H Potocki, T Palmetzhofer, U Koller, ... International journal of molecular sciences 22 (7), 3326, 2021 | 18 | 2021 |
| Extracellular vesicles as biomarkers for the detection of a tumor marker gene in epidermolysis bullosa-associated squamous cell carcinoma Y Sun, K Woess, M Kienzl, VM Leb-Reichl, A Feinle, M Wimmer, R Zauner, ... The Journal of investigative dermatology 138 (5), 1197-1200, 2018 | 18 | 2018 |
| Basal pharmacokinetic parameters of topically applied diacerein in pediatric patients with generalized severe epidermolysis bullosa simplex M Ablinger, TK Felder, M Wimmer, R Zauner, P Hofbauer, T Lettner, ... Orphanet Journal of Rare Diseases 13, 1-5, 2018 | 9 | 2018 |
| Enhanced deposition by electrostatic field-assistance aggravating diesel exhaust aerosol toxicity for human lung cells LC Stoehr, P Madl, MSP Boyles, R Zauner, M Wimmer, H Wiegand, ... Environmental Science & Technology 49 (14), 8721-8730, 2015 | 8 | 2015 |
| Metformin shows anti‐neoplastic properties by inhibition of oxidative phosphorylation and glycolysis in epidermolysis bullosa‐associated aggressive cutaneous squamous cell … T Welponer, DD Weber, L Trattner, B Tockner, S Aminzadeh‐Gohari, ... Journal of the European Academy of Dermatology and Venereology 38 (1), 112-123, 2024 | 4 | 2024 |
| Biomarker Discovery in Rare Malignancies: Development of a miRNA Signature for RDEB-cSCC R Zauner, M Wimmer, S Atzmueller, J Proell, N Niklas, M Ablinger, ... Cancers 15 (13), 3286, 2023 | 4 | 2023 |
| Chondroitin sulfate proteoglycan 4 as a marker for aggressive squamous cell carcinoma K Chen, J Yong, R Zauner, V Wally, J Whitelock, M Sajinovic, Z Kopecki, ... Cancers 14 (22), 5564, 2022 | 4 | 2022 |
| MicroRNA-200b-mediated reversion of a spectrum of epithelial-to-mesenchymal transition states in recessive dystrophic epidermolysis bullosa squamous cell carcinomas J Illmer, R Zauner, J Piñón Hofbauer, M Wimmer, S Gruner, M Ablinger, ... British Journal of Dermatology 190 (1), 80-93, 2024 | 3 | 2024 |
| Transcriptome-guided drug repurposing for aggressive SCCs R Zauner, M Wimmer, S Dorfer, M Ablinger, U Koller, J Piñón Hofbauer, ... International Journal of Molecular Sciences 23 (2), 1007, 2022 | 3 | 2022 |
| MicroRNA-30d-5p—A Potential New Therapeutic Target for Prevention of Ischemic Cardiomyopathy after Myocardial Infarction E Boxhammer, V Paar, B Wernly, A Kiss, M Mirna, A Aigner, E Acar, ... Cells 12 (19), 2369, 2023 | 2 | 2023 |
| 181 Investigating the potential of repurposing diacerein for the treatment of cutaneous wounds in recessive dystrophic epidermolysis bullosa S Dorfer, M Ablinger, M Wimmer, S Ibrahimpasic, J Illmer, JW Bauer, ... Journal of Investigative Dermatology 143 (11), S363, 2023 | | 2023 |
| Methylome profiling identifies recessive dystrophic epidermolysis bullosa-specific epigenetic patterns in keratinocytes J Illmer, M Wimmer, R Zauner, M Ablinger, S Dorfer, S Bergson, O Sarig, ... Journal of Investigative Dermatology 143 (5), S144-S144, 2023 | | 2023 |
| HMCN1 variants aggravate epidermolysis bullosa phenotype S Bergson, O Sarig, A Nitzan, S Hainzl, T Kocher, M Giladi, J Illmer, ... Journal of Investigative Dermatology 143 (5), S146-S146, 2023 | | 2023 |
| Agomir of miRNA-30d–a potential new therapeutic target for prevention of ischemic cardiomyopathy after myocardial infarction? E Boxhammer, B Wernly, A Kiss, V Paar, A Aigner, BK Podesser, ... European Heart Journal 43 (Supplement_2), ehac544. 2904, 2022 | | 2022 |
| Differential regulation of miR-200b in squamous cell carcinoma of patients with recessive dystrophic epidermolysis bullosa J Illmer, M Wimmer, R Zauner, M Ablinger, J Bischof, V Tober, S Atzmuller, ... Journal of Investigative Dermatology 142 (12), S262-S262, 2022 | | 2022 |
| MiRNA-10b marks aggressive squamous cell carcinomas, and confers a cancer stem cell-like phenotype M Wimmer, R Zauner, M Ablinger, J Piñón-Hofbauer, C Guttmann-Gruber, ... bioRxiv, 2020.02. 05.934109, 2020 | | 2020 |
| MIRNA-10B MARKS AGGRESSIVE SQUAMOUS CELL CARCINOMAS IN RDEB M Wimmer, R Zauner, M Ablinger, J Pinon-Hofbauer, C Guttmann-Gruber, ... ACTA DERMATO-VENEREOLOGICA 100, 35-36, 2020 | | 2020 |
| MiR-10b as a marker for disseminated disease in RDEB-linked SCCs MM Shah, H Bodocian, R Zauner, M Sajinovic, P De Souza, V Wally, ... ACTA DERMATO-VENEREOLOGICA 100, 60-61, 2020 | | 2020 |
| CIRCULATING CELL-FREE MIRNA SCREENING FOR RDEB-SCC BIOMARKER IDENTIFICATION R Zauner, M Wimmer, M Ablinger, T Lettner, S Atzmuller, J Proll, J Bauer, ... ACTA DERMATO-VENEREOLOGICA 100, 37-37, 2020 | | 2020 |
